Contineum Therapeutics
CTNM
#7294
Rank
$0.35 B
Marketcap
$13.75
Share price
-2.20%
Change (1 day)
N/A
Change (1 year)

Contineum Therapeutics (CTNM) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $5.8 Million USD

According to Contineum Therapeutics's latest financial reports the company's total liabilities are $5.8 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Contineum Therapeutics - Total liabilities on balance sheet (from 2022 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.19 B37.87%
2022-12-31$0.14 B1.72%
2021-12-31$0.14 B